UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB Number:  3235-0582

 

Expires:  January 31, 2015

 

Estimated average burden hours per response........9.6

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Life Sciences Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

 

Date of fiscal year end:  September 30

 

 

Date of reporting period:  7/1/12-6/30/13

 

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

Vote Summary

 

A.P. PHARMA, INC.

 

Security

00202J203

 

Meeting Type

Annual

Ticker Symbol

APPA

 

Meeting Date

12-Jun-2013

Record Date

03-May-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEVIN TANG

 

 

 

For

 

For

 

 

 

2

STEPHEN R. DAVIS

 

 

 

For

 

For

 

 

 

3

B.D. QUART, PHARM. D.

 

 

 

For

 

For

 

 

 

4

ROBERT ROSEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF OUM & CO. LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED PURSUANT TO ITEM 402 OF REGULATION S-K, INCLUDING THE COMPENSATION TABLES AND NARRATIVE DISCUSSION.

 

Management

 

For

 

For

 

4.

 

TO RECOMMEND, IN A NON-BINDING VOTE, THE FREQUENCY OF ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

1 Year

 

For

 

 

ACCURAY INCORPORATED

 

Security

004397105

 

Meeting Type

Annual

Ticker Symbol

ARAY

 

Meeting Date

30-Nov-2012

Record Date

05-Oct-2012

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: ELIZABETH DAVILA

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: JOSHUA H. LEVINE

 

Management

 

For

 

For

 

2

 

ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (SAY-ON-PAY VOTE).

 

Management

 

For

 

For

 

3

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF TOTAL AUTHORIZED SHARES FROM 105,000,000 TO 205,000,000 AND THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 100,000,000 TO 200,000,000.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2013.

 

Management

 

For

 

For

 

 

ACORDA THERAPEUTICS, INC.

 

Security

00484M106

 

Meeting Type

Annual

Ticker Symbol

ACOR

 

Meeting Date

30-May-2013

Record Date

02-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

PEDER K. JENSEN, M.D.

 

 

 

For

 

For

 

 

 

2

JOHN P. KELLEY

 

 

 

For

 

For

 

 

 

3

SANDRA PANEM, PH.D.

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

ACTAVIS, INC.

 

Security

00507K103

 

Meeting Type

Annual

Ticker Symbol

ACT

 

Meeting Date

10-May-2013

 


 

Record Date

15-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JACK MICHELSON

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RONALD R. TAYLOR

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ANDREW L. TURNER

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: PAUL M. BISARO

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: CHRISTOPHER W. BODINE

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHEL J. FELDMAN

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: FRED G. WEISS

 

Management

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

4.

 

TO VOTE ON A PROPOSAL SUBMITTED BY A STOCKHOLDER TO REQUEST THAT THE COMPANY ADOPT A POLICY REQUIRING ITS SENIOR EXECUTIVES TO RETAIN A SIGNIFICANT PERCENTAGE OF THE COMPANY SHARES THEY ACQUIRE THROUGH THE COMPANY’S EQUITY COMPENSATION PROGRAMS UNTIL REACHING RETIREMENT AGE.

 

Shareholder

 

Against

 

For

 

 

AKORN, INC.

 

Security

009728106

 

Meeting Type

Annual

Ticker Symbol

AKRX

 

Meeting Date

03-May-2013

Record Date

08-Mar-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN N. KAPOOR, PHD

 

 

 

For

 

For

 

 

 

2

RONALD M. JOHNSON

 

 

 

For

 

For

 

 

 

3

BRIAN TAMBI

 

 

 

For

 

For

 

 

 

4

STEVEN J. MEYER

 

 

 

For

 

For

 

 

 

5

ALAN WEINSTEIN

 

 

 

For

 

For

 

 

 

6

KENNETH S. ABRAMOWITZ

 

 

 

For

 

For

 

 

 

7

ADRIENNE L. GRAVES, PHD

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE SELECTION OF KPMG LLP TO SERVE AS AKORN’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

Management

 

For

 

For

 

 

ALERE INC.

 

Security

01449J105

 

Meeting Type

Annual

Ticker Symbol

ALR

 

Meeting Date

11-Jul-2012

Record Date

17-May-2012

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CAROL R. GOLDBERG

 

 

 

For

 

For

 

 

 

2

JAMES ROOSEVELT, JR.

 

 

 

For

 

For

 

 

 

3

RON ZWANZIGER

 

 

 

For

 

For

 

2

 

APPROVAL OF AN AMENDMENT TO ALERE INC.`S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO DECLASSIFY THE BOARD OF DIRECTORS.

 

Management

 

For

 

For

 

3

 

APPROVAL OF AN INCREASE TO THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE ALERE INC. 2010 STOCK OPTION AND INCENTIVE PLAN BY 2,000,000, FROM 3,153,663 TO 5,153,663.

 

Management

 

For

 

For

 

 


 

4

 

APPROVAL OF THE GRANTING OF OPTIONS UNDER OUR 2010 STOCK OPTION AND INCENTIVE PLAN TO CERTAIN EXECUTIVE OFFICERS; PROVIDED THAT, EVEN IF THIS PROPOSAL IS APPROVED BY OUR STOCKHOLDERS, WE DO NOT INTEND TO IMPLEMENT THIS PROPOSAL UNLESS PROPOSAL 3 IS ALSO APPROVED.

 

Management

 

For

 

For

 

5

 

RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2012.

 

Management

 

For

 

For

 

6

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 

ALEXION PHARMACEUTICALS, INC.

 

Security

015351109

 

Meeting Type

Annual

Ticker Symbol

ALXN

 

Meeting Date

06-May-2013

Record Date

11-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LEONARD BELL

 

 

 

For

 

For

 

 

 

2

MAX LINK

 

 

 

For

 

For

 

 

 

3

WILLIAM R. KELLER

 

 

 

For

 

For

 

 

 

4

JOSEPH A. MADRI

 

 

 

For

 

For

 

 

 

5

LARRY L. MATHIS

 

 

 

For

 

For

 

 

 

6

R. DOUGLAS NORBY

 

 

 

For

 

For

 

 

 

7

ALVIN S. PARVEN

 

 

 

For

 

For

 

 

 

8

ANDREAS RUMMELT

 

 

 

For

 

For

 

 

 

9

ANN M. VENEMAN

 

 

 

For

 

For

 

2.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2012 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 


 

3.

 

APPROVAL OF THE AMENDED AND RESTATED 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 12 MILLION SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS).

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

 

ALKERMES PLC

 

Security

G01767105

 

Meeting Type

Annual

Ticker Symbol

ALKS

 

Meeting Date

01-Aug-2012

Record Date

15-Jun-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

FLOYD E. BLOOM

 

 

 

For

 

For

 

 

 

2

GERALDINE A. HENWOOD

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN TO INCREASE THE SHARES AVAILABLE FOR ISSUANCE FROM 8,350,000 TO 12,550,000.

 

Management

 

For

 

For

 

3.

 

TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO HOLD A NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.

 

Management

 

1 Year

 

For

 

5.

 

TO AUTHORIZE HOLDING THE 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY AT A LOCATION OUTSIDE OF IRELAND.

 

Management

 

For

 

For

 

 


 

6.

 

TO APPOINT PRICEWATERHOUSECOOPERS AS THE INDEPENDENT AUDITORS OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

 

AMARIN CORPORATION PLC

 

Security

023111206

 

Meeting Type

Annual

Ticker Symbol

AMRN

 

Meeting Date

09-Jul-2013

Record Date

22-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

O1

 

TO RE-ELECT MR. JOSEPH S. ZAKRZEWSKI AS A DIRECTOR

 

Management

 

For

 

For

 

O2

 

TO RE-ELECT MS. KRISTINE PETERSON AS A DIRECTOR

 

Management

 

For

 

For

 

O3

 

TO ELECT MR. DAVID STACK AS A DIRECTOR

 

Management

 

For

 

For

 

O4

 

TO HOLD AN ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S “NAMED EXECUTIVE OFFICERS” AS DESCRIBED IN THE COMPENSATION DISCUSSION AND ANALYSIS SECTION, THE TABULAR DISCLOSURE REGARDING SUCH COMPENSATION, AND THE ACCOMPANYING NARRATIVE DISCLOSURE SET FORTH IN THE ENCLOSED PROXY STATEMENT

 

Management

 

For

 

For

 

O5

 

TO HOLD AN ADVISORY (NON-BINDING) VOTE TO APPROVE THE DIRECTORS’ REMUNERATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012

 

Management

 

For

 

For

 

O6

 

TO APPOINT DELOITTE & TOUCHE LLP AS AUDITORS TO HOLD OFFICE UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING AT WHICH ACCOUNTS ARE LAID BEFORE THE COMPANY AND TO AUTHORIZE THE AUDIT COMMITTEE OF BOARD OF DIRECTORS TO FIX AUDITORS’ REMUNERATION

 

Management

 

For

 

For

 

 


 

S7

 

TO AMEND THE COMPANY’S ARTICLES OF ASSOCIATION TO REMOVE A BORROWING LIMITATION ON THE COMPANY BY DELETING ARTICLES 143(B) TO (E) (INCLUSIVE)

 

Management

 

For

 

For

 

 

AMGEN INC.

 

Security

031162100

 

Meeting Type

Annual

Ticker Symbol

AMGN

 

Meeting Date

22-May-2013

Record Date

25-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: DR. DAVID BALTIMORE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MR. ROBERT A. ECKERT

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: DR. TYLER JACKS

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: DR. GILBERT S. OMENN

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: MR. LEONARD D. SCHAEFFER

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR: DR. RONALD D. SUGAR

 

Management

 

For

 

For

 

 


 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

APPROVAL OF OUR PROPOSED AMENDED AND RESTATED 2009 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

ANTISOMA PLC

 

Security

03248123

 

Meeting Type

Annual

Ticker Symbol

ASM.L

 

Meeting Date

25-Oct-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO RECEIVE AND ADOPT THE DIRECTORS REPORT.

 

Management

 

For

 

For

 

2.

 

RE-ELECT MICHAEL BRETHERTON.

 

Management

 

For

 

For

 

3.

 

RE-ELECT JONATHAN MORLEY-KIRK.

 

Management

 

For

 

For

 

4.

 

TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITORS OF THE COMPANY AND TO AUTHORISE THE DIRECTORS TO DETERMINE THEIR RENUMERATION YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

Management

 

For

 

For

 

5.

 

TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITOR’S FEES.

 

Management

 

For

 

For

 

6.

 

TO AUTHORISE THE DIRECTORS TO ALLOT SHARES.

 

Management

 

For

 

For

 

7.

 

TO AUTHORISE THE DISAPPLICATION OF STATUTORY PRE-EMPTION RIGHTS.

 

Management

 

For

 

For

 

 

ARIAD PHARMACEUTICALS, INC.

 

Security

04033A100

 

Meeting Type

Annual

Ticker Symbol

ARIA

 

Meeting Date

20-Jun-2013

Record Date

25-Apr-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ATHANASE LAVIDAS, PH.D

 

 

 

For

 

For

 

 

 

2

MASSIMO RADAELLI, PH.D.

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 240 MILLION TO 450 MILLION SHARES.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

 

BIOGEN IDEC INC.

 

Security

09062X103

 

Meeting Type

Annual

Ticker Symbol

BIIB

 

Meeting Date

12-Jun-2013

Record Date

15-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

Management

 

For

 

For

 

 


 

1I.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: WILLIAM D. YOUNG

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN IDEC INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO REAPPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS UNDER THE BIOGEN IDEC INC. 2008 PERFORMANCE- BASED MANAGEMENT INCENTIVE PLAN FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE.

 

Management

 

For

 

For

 

5.

 

TO REAPPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS UNDER THE BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE.

 

Management

 

For

 

For

 

6.

 

SHAREHOLDER PROPOSAL REGARDING ADOPTION OF A SHARE RETENTION POLICY.

 

Shareholder

 

Against

 

For

 

 

CARDIOKINETIX, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

18-Feb-2013

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

CERTIFICATE OF AMENDEMNT OF SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

APPROVE THE AMENDEMENT OF THE 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF COMMON STOCK RESERVED FOR ISSUANCE BY 972,677.

 

Management

 

For

 

For

 

3.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

14-Dec-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

ADOPT AND APPROVE THE AMENDMENT TO THE CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

CELGENE CORPORATION

 

Security

151020104

 

Meeting Type

Annual

Ticker Symbol

CELG

 

Meeting Date

12-Jun-2013

Record Date

17-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. HUGIN

 

 

 

For

 

For

 

 

 

2

R.W. BARKER, D. PHIL.

 

 

 

For

 

For

 

 

 

3

MICHAEL D. CASEY

 

 

 

For

 

For

 

 


 

 

 

4

CARRIE S. COX

 

 

 

For

 

For

 

 

 

5

RODMAN L. DRAKE

 

 

 

For

 

For

 

 

 

6

M.A. FRIEDMAN, M.D.

 

 

 

For

 

For

 

 

 

7

GILLA KAPLAN, PH.D.

 

 

 

For

 

For

 

 

 

8

JAMES J. LOUGHLIN

 

 

 

For

 

For

 

 

 

9

ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

Against

 

For

 

 

CELLDEX THERAPEUTICS, INC.

 

Security

15117B103

 

Meeting Type

Annual

Ticker Symbol

CLDX

 

Meeting Date

12-Jun-2013

Record Date

15-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LARRY ELLBERGER

 

 

 

For

 

For

 

 

 

2

ANTHONY S. MARUCCI

 

 

 

For

 

For

 

 

 

3

HERBERT J. CONRAD

 

 

 

For

 

For

 

 

 

4

GEORGE O. ELSTON

 

 

 

For

 

For

 

 

 

5

HARRY H. PENNER, JR.

 

 

 

For

 

For

 

 

 

6

TIMOTHY M. SHANNON

 

 

 

For

 

For

 

 

 

7

KAREN L. SHOOS

 

 

 

For

 

For

 

2

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 


 

3

 

TO APPROVE AN AMENDMENT TO OUR 2004 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE SHARES RESERVED FOR ISSUANCE THEREUNDER BY 137,500 TO 200,000.

 

Management

 

For

 

For

 

4

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT.

 

Management

 

For

 

For

 

 

CERES, INC.

 

Security

156773103

 

Meeting Type

Annual

Ticker Symbol

CERE

 

Meeting Date

08-Feb-2013

Record Date

20-Dec-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RAYMOND DEBBANE

 

 

 

For

 

For

 

 

 

2

ROBERT GOLDBERG

 

 

 

For

 

For

 

 

 

3

THOMAS KILEY

 

 

 

For

 

For

 

 

 

4

STEVEN KOONIN

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY AND APPROVE THE AMENDED AND RESTATED CERES, INC. 2011 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING AUGUST 31, 2013.

 

Management

 

For

 

For

 

 

CERES, INC.

 

Security

156773103

 

Meeting Type

Annual

Ticker Symbol

CERE

 

Meeting Date

15-Aug-2012

Record Date

09-Jul-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO AMEND THE 2000 STOCK OPTION/STOCK ISSUANCE PLAN TO EXTEND THE TERM OF OUTSTANDING OPTIONS TO PURCHASE 403,666 SHARES OF COMMON STOCK THAT WERE GRANTED UNDER THE 2000 PLAN AND THAT ARE SCHEDULED TO EXPIRE ON DECEMBER 18, 2012 TO THIRTEEN YEARS FROM THEIR DATE OF GRANT.

 

Management

 

For

 

For

 

 

COVANCE INC.

 

Security

222816100

 

Meeting Type

Annual

Ticker Symbol

CVD

 

Meeting Date

07-May-2013

Record Date

13-Mar-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOSEPH L. HERRING

 

 

 

For

 

For

 

 

 

2

JOHN MCCARTNEY

 

 

 

For

 

For

 

 

 

3

B.T. SHEARES, PH.D.

 

 

 

For

 

For

 

2.

 

ADVISORY APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE 2013 EMPLOYEE EQUITY PARTICIPATION PLAN.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP FOR THE FISCAL YEAR 2013.

 

Management

 

For

 

For

 

 

CUBIST PHARMACEUTICALS, INC.

 

Security

229678107

 

Meeting Type

Annual

Ticker Symbol

CBST

 

Meeting Date

12-Jun-2013

Record Date

16-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MR. MICHAEL BONNEY

 

 

 

For

 

For

 

 

 

2

MARK CORRIGAN, M.D.

 

 

 

For

 

For

 

 

 

3

MS. ALISON LAWTON

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO IMPLEMENT A MAJORITY VOTING STANDARD IN UNCONTESTED ELECTIONS OF DIRECTORS BEGINNING WITH OUR 2014 ANNUAL MEETING OF STOCKHOLDERS.

 

Management

 

For

 

For

 

4.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO MAKE CERTAIN CHANGES RELATED TO CUBIST’S RECENT SEPARATION OF THE ROLES OF CHIEF EXECUTIVE OFFICER AND PRESIDENT.

 

Management

 

For

 

For

 

 


 

5.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO MAKE CERTAIN CHANGES REGARDING THE CONDUCT OF, AND PROCEDURES FOR, OUR STOCKHOLDER MEETINGS.

 

Management

 

For

 

For

 

6.

 

APPROVAL OF THE AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

7.

 

RATIFICATION OF OUR SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

CURIS, INC.

 

Security

231269101

 

Meeting Type

Annual

Ticker Symbol

CRIS

 

Meeting Date

30-May-2013

Record Date

01-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT E. MARTELL

 

 

 

For

 

For

 

 

 

2

DANIEL R. PASSERI

 

 

 

For

 

For

 

 

 

3

MARC RUBIN

 

 

 

For

 

For

 

2.

 

TO APPROVE THE AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR

 

Management

 

For

 

For

 

 

ENDO HEALTH SOLUTIONS INC.

 

Security

29264F205

 

Meeting Type

Annual

Ticker Symbol

ENDP

 

Meeting Date

22-May-2013

Record Date

01-Apr-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RAJIV DE SILVA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JOHN J. DELUCCA

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: DAVID B. NASH, M.D., M.B.A.

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: JOSEPH C. SCODARI

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: JILL D. SMITH

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

ENDOCYTE INC

 

Security

29269A102

 

Meeting Type

Annual

Ticker Symbol

ECYT

 

Meeting Date

19-Jun-2013

Record Date

22-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: P. RON ELLIS

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: MARC D. KOZIN

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: FRED A. MIDDLETON

 

Management

 

For

 

For

 

 


 

2.

 

RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

 

EUTHYMICS BIOSCIENCES, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

19-Nov-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

GENERAL MATTERS.

 

Management

 

For

 

For

 

2.

 

ADOPT AND APPROVE THE SEVENTH AMENDED AND RESTARTED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

3.

 

APPROVE THE AMENDMENT TO THE 2010 EQUITY INCENTIVE PLAN INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE TO 5,989,667.

 

Management

 

For

 

For

 

 

GEN-PROBE INCORPORATED

 

Security

36866T103

 

Meeting Type

Special

Ticker Symbol

GPRO

 

Meeting Date

31-Jul-2012

Record Date

29-Jun-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

PROPOSAL TO ADOPT THE AGREEMENT AND PLAN OF MERGER BY AND AMONG GEN-PROBE INCORPORATED, HOLOGIC, INC. AND GOLD ACQUISITION CORP., AS IT MAY BE AMENDED FROM TIME TO TIME (THE “AGREEMENT AND PLAN OF MERGER”).

 

Management

 

For

 

For

 

2.

 

PROPOSAL TO ADJOURN THE SPECIAL MEETING TO A LATER DATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO APPROVE PROPOSAL 1 AT THE TIME OF THE SPECIAL MEETING.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO APPROVE, ON A NON- BINDING ADVISORY BASIS, CERTAIN COMPENSATION ARRANGEMENTS FOR GEN-PROBE INCORPORATED’S NAMED EXECUTIVE OFFICERS IN CONNECTION WITH THE AGREEMENT AND PLAN OF MERGER.

 

Management

 

For

 

For

 

 

GILEAD SCIENCES, INC.

 

Security

375558103

 

Meeting Type

Annual

Ticker Symbol

GILD

 

Meeting Date

08-May-2013

Record Date

13-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN F. COGAN

 

 

 

For

 

For

 

 


 

 

 

2

ETIENNE F. DAVIGNON

 

 

 

For

 

For

 

 

 

3

CARLA A. HILLS

 

 

 

For

 

For

 

 

 

4

KEVIN E. LOFTON

 

 

 

For

 

For

 

 

 

5

JOHN W. MADIGAN

 

 

 

For

 

For

 

 

 

6

JOHN C. MARTIN

 

 

 

For

 

For

 

 

 

7

NICHOLAS G. MOORE

 

 

 

For

 

For

 

 

 

8

RICHARD J. WHITLEY

 

 

 

For

 

For

 

 

 

9

GAYLE E. WILSON

 

 

 

For

 

For

 

 

 

10

PER WOLD-OLSEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE A RESTATEMENT OF GILEAD SCIENCES, INC.’S 2004 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO GILEAD’S RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

5.

 

TO APPROVE, ON THE ADVISORY BASIS, THE COMPENSATION OF GILEAD’S NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

6.

 

TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR, IF PROPERLY PRESENTED AT THE MEETING.

 

Shareholder

 

For

 

Against

 

7.

 

TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT, IF PROPERLY PRESENTED AT THE MEETING.

 

Shareholder

 

Against

 

For

 

 

HOLOGIC, INC.

 

Security

436440101

 

Meeting Type

Annual

Ticker Symbol

HOLX

 

Meeting Date

11-Mar-2013

Record Date

11-Jan-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DAVID R. LAVANCE, JR.

 

 

 

For

 

For

 

 

 

2

ROBERT A. CASCELLA

 

 

 

For

 

For

 

 

 

3

GLENN P. MUIR

 

 

 

For

 

For

 

 

 

4

SALLY W. CRAWFORD

 

 

 

For

 

For

 

 

 

5

NANCY L. LEAMING

 

 

 

For

 

For

 

 

 

6

LAWRENCE M. LEVY

 

 

 

For

 

For

 

 

 

7

CHRISTIANA STAMOULIS

 

 

 

For

 

For

 

 

 

8

ELAINE S. ULLIAN

 

 

 

For

 

For

 

 

 

9

WAYNE WILSON

 

 

 

For

 

For

 

2.

 

TO APPROVE THE HOLOGIC, INC. AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

A NON-BINDING ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

 

IDEXX LABORATORIES, INC.

 

Security

45168D104

 

Meeting Type

Annual

Ticker Symbol

IDXX

 

Meeting Date

08-May-2013

Record Date

11-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JONATHAN W. AYERS

 

 

 

For

 

For

 

 

 

2

ROBERT J. MURRAY

 

 

 

For

 

For

 

 

 

3

M. ANNE SZOSTAK

 

 

 

For

 

For

 

 


 

2.

 

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

Management

 

For

 

For

 

3.

 

AMENDMENTS TO IDEXX LABORATORIES, INC. 2009 STOCK INCENTIVE PLAN. TO APPROVE PROPOSED AMENDMENTS TO OUR 2009 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR.

 

Management

 

For

 

For

 

 

ILLUMINA, INC.

 

Security

452327109

 

Meeting Type

Annual

Ticker Symbol

ILMN

 

Meeting Date

29-May-2013

Record Date

02-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GERALD MOLLER, PH.D.*

 

 

 

For

 

For

 

 

 

2

DAVID R. WALT, PH.D.*

 

 

 

For

 

For

 

 

 

3

R.S. EPSTEIN, M.D.#

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 29, 2013

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT

 

Management

 

For

 

For

 

 


 

4.

 

TO APPROVE AN AMENDMENT TO THE ILLUMINA, INC. 2005 STOCK AND INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE BY 5,000,000 SHARES AND TO EXTEND THE TERMINATION DATE OF THE PLAN UNTIL JUNE 28, 2016

 

Management

 

For

 

For

 

 

ILLUMINOSS MEDICAL, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

20-Dec-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

FIRST AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2.

 

SETTLEMENT AND RELEASE AGREEMENT INTERESTED DIRECTOR RESOLUTIONS

 

Management

 

For

 

For

 

3.

 

AMENDMENT AND WAIVER AGREEMENT INTERESTED DIRECTIOR RESOLUTIONS

 

Management

 

For

 

For

 

4.

 

ADDITIONAL PREFERRED STOCK FINANCING INTERESTED DIRECTOR RESOLUTION

 

Management

 

For

 

For

 

5.

 

GENERAL MATTERS

 

Management

 

For

 

For

 

 

IMMUNOGEN, INC.

 

Security

45253H101

 

Meeting Type

Annual

Ticker Symbol

IMGN

 

Meeting Date

13-Nov-2012

Record Date

18-Sep-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO FIX THE NUMBER OF MEMBERS OF THE BOARD OF DIRECTORS AT TEN (10).

 

Management

 

For

 

For

 

2.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MARK SKALETSKY

 

 

 

For

 

For

 

 

 

2

J. J. VILLAFRANCA PH.D.

 

 

 

For

 

For

 

 

 

3

NICOLE ONETTO, MD

 

 

 

For

 

For

 

 

 

4

STEPHEN C. MCCLUSKI

 

 

 

For

 

For

 

 

 

5

RICHARD J. WALLACE

 

 

 

For

 

For

 

 

 

6

DANIEL M. JUNIUS

 

 

 

For

 

For

 

 

 

7

HOWARD H. PIEN

 

 

 

For

 

For

 

 

 

8

MARK GOLDBERG, MD

 

 

 

For

 

For

 

 

 

9

DEAN J. MITCHELL

 

 

 

For

 

For

 

 

 

10

KRISTINE PETERSON

 

 

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE 2006 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 3,500,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO THE RESTATED ARTICLES OF ORGANIZATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 100,000,000 TO 150,000,000.

 

Management

 

For

 

For

 

 


 

5.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN OUR PROXY STATEMENT.

 

Management

 

For

 

For

 

6.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS IMMUNOGEN’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2013.

 

Management

 

For

 

For

 

 

IMPAX LABORATORIES, INC.

 

Security

45256B101

 

Meeting Type

Annual

Ticker Symbol

IPXL

 

Meeting Date

14-May-2013

Record Date

05-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LESLIE Z. BENET, PH.D.

 

 

 

For

 

For

 

 

 

2

ROBERT L. BURR

 

 

 

For

 

For

 

 

 

3

ALLEN CHAO, PH.D.

 

 

 

For

 

For

 

 

 

4

NIGEL TEN FLEMING, PHD

 

 

 

For

 

For

 

 

 

5

LARRY HSU, PH.D.

 

 

 

For

 

For

 

 

 

6

MICHAEL MARKBREITER

 

 

 

For

 

For

 

 

 

7

PETER R. TERRERI

 

 

 

For

 

For

 

2.

 

TO APPROVE THE SECOND AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2002 EQUITY INCENTIVE PLAN TO, AMONG OTHER ITEMS, INCREASE THE AGGREGATE NUMBER OF SHARES OF THE COMPANY’S COMMON STOCK THAT MAY BE ISSUED UNDER SUCH PLAN BY 3.15 MILLION SHARES.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 


 

4.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

INCYTE CORPORATION

 

Security

45337C102

 

Meeting Type

Annual

Ticker Symbol

INCY

 

Meeting Date

30-May-2013

Record Date

02-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RICHARD U. DE SCHUTTER

 

 

 

For

 

For

 

 

 

2

BARRY M. ARIKO

 

 

 

For

 

For

 

 

 

3

JULIAN C. BAKER

 

 

 

For

 

For

 

 

 

4

PAUL A. BROOKE

 

 

 

For

 

For

 

 

 

5

WENDY L. DIXON

 

 

 

For

 

For

 

 

 

6

PAUL A. FRIEDMAN

 

 

 

For

 

For

 

 

 

7

ROY A. WHITFIELD

 

 

 

For

 

For

 

2.

 

TO APPROVE THE COMPANY’S AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

 

INTELLIPHARMACEUTICALS INTERNATIONAL INC.

 

Security

458173101

 

Meeting Type

Annual

Ticker Symbol

IPCI

 

Meeting Date

28-Mar-2013

Record Date

19-Feb-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1 a.

 

ELECT DIRECTOR DR. ISA ODIDI

 

Management

 

For

 

For

 

1 b.

 

ELECT DIRECTOR DR. AMINA ODIDI

 

Management

 

For

 

For

 

1 c.

 

ELECT DIRECTOR JOHN ALLPORT

 

Management

 

For

 

For

 

1 d.

 

ELECT DIRECTOR BAHADUR MADHANI

 

Management

 

For

 

For

 

1 e.

 

ELECT DIRECTOR KENNETH KEIRSTEAD

 

Management

 

For

 

For

 

1 f.

 

ELECT DIRECTOR DR. ELDON R. SMITH

 

Management

 

For

 

For

 

2.

 

REAPPOINTMENT OF DELOITTE LLP AS THE AUDITOR OF THE COMPANY AND TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITOR’S RENUMERATION.

 

Management

 

For

 

For

 

 

IRONWOOD PHARMACEUTICALS, INC.

 

Security

46333X108

 

Meeting Type

Annual

Ticker Symbol

IRWD

 

Meeting Date

04-Jun-2013

Record Date

09-Apr-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MARSHA H. FANUCCI

 

 

 

For

 

For

 

 

 

2

TERRANCE G. MCGUIRE

 

 

 

For

 

For

 

 

 

3

EDWARD P. OWENS

 

 

 

For

 

For

 

 

 

4

CHRISTOPHER T. WALSH

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

 

LABCYTE, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

10-Jul-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

RATIFY AND APPROVE AN INCREASE TO THE AUTHORIZED NUMBER OF DIRECTORS OF THE CORPORATION.

 

Management

 

For

 

For

 

2.

 

GENERAL MATTERS.

 

Management

 

For

 

For

 

 

MACROGENICS, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

08-Nov-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE THE AMENDMENT TO THE 2003 EQUITY INCENTIVE PLAN TO INCREASE THE MAXIMUM NUMBER OF SHARES OF COMMON STOCK AUTHORIZED TO BE ISSUED BY THE COMPANY BY 10,250,000 SHARES, AND TO AUTHORIZE THE OFFICERS OF THE COMPANY TO TAKE FURTHER ACTION, EXECUTE ADDITIONAL DOCUMENTS AS DEEMED NECESSARY AND CARRY OUT THE RESOLUTIONS ADOPTED HEREBY.

 

Management

 

For

 

For

 

 

MEDIVATION, INC.

 

Security

58501N101

 

Meeting Type

Annual

Ticker Symbol

MDVN

 

Meeting Date

13-Jul-2012

Record Date

25-May-2012

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DANIEL D. ADAMS

 

 

 

For

 

For

 

 

 

2

GREGORY H. BAILEY, M.D.

 

 

 

For

 

For

 

 

 

3

KIM D. BLICKENSTAFF

 

 

 

For

 

For

 

 

 

4

DAVID T. HUNG, M.D.

 

 

 

For

 

For

 

 

 

5

W. ANTHONY VERNON

 

 

 

For

 

For

 

2

 

TO APPROVE MEDIVATION’S AMENDED AND RESTATED 2004 EQUITY INCENTIVE AWARD PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 1,800,000 SHARES (ON A PRE-SPLIT BASIS) AND TO APPROVE THE PLAN’S PERFORMANCE CRITERIA AND AWARD LIMITS.

 

Management

 

Against

 

Against

 

3

 

TO APPROVE AN AMENDMENT TO MEDIVATION’S RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF MEDIVATION’S COMMON STOCK FROM 50,000,000 SHARES TO 85,000,000 SHARES (ON A PRE-SPLIT BASIS).

 

Management

 

For

 

For

 

 


 

4

 

TO APPROVE AN AMENDMENT TO MEDIVATION’S RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO EFFECT A TWO-FOR-ONE STOCK SPLIT, WITH A PROPORTIONATE INCREASE IN THE NUMBER OF AUTHORIZED SHARES OF MEDIVATION’S COMMON STOCK.

 

Management

 

For

 

For

 

5

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS MEDIVATION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

Management

 

For

 

For

 

6

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF MEDIVATION’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT.

 

Management

 

For

 

For

 

 

MEDIVATION, INC.

 

Security

58501N101

 

Meeting Type

Annual

Ticker Symbol

MDVN

 

Meeting Date

28-Jun-2013

Record Date

29-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DANIEL D. ADAMS

 

 

 

For

 

For

 

 

 

2

KIM D. BLICKENSTAFF

 

 

 

For

 

For

 

 

 

3

KATHRYN E. FALBERG

 

 

 

For

 

For

 

 

 

4

DAWN GRAHAM

 

 

 

For

 

For

 

 

 

5

DAVID T. HUNG, M.D.

 

 

 

For

 

For

 

 

 

6

W. ANTHONY VERNON

 

 

 

For

 

For

 

 

 

7

WENDY L. YARNO

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS MEDIVATION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 


 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF MEDIVATION’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE MEDIVATION, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

5.

 

TO APPROVE THE MEDIVATION, INC. AMENDED AND RESTATED 2004 EQUITY INCENTIVE AWARD PLAN.

 

Management

 

Against

 

Against

 

6.

 

TO APPROVE THE MEDIVATION, INC. 2013 CASH PERFORMANCE INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

MERRIMACK PHARMACEUTICALS, INC.

 

Security

590328100

 

Meeting Type

Annual

Ticker Symbol

MACK

 

Meeting Date

11-Jun-2013

Record Date

15-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. MULROY

 

 

 

For

 

For

 

 

 

2

GARY L. CROCKER

 

 

 

For

 

For

 

 

 

3

JAMES VAN B. DRESSER

 

 

 

For

 

For

 

 

 

4

GORDON J. FEHR

 

 

 

For

 

For

 

 

 

5

JOHN MENDELSOHN, MD

 

 

 

For

 

For

 

 

 

6

SARAH E. NASH

 

 

 

For

 

For

 

 

 

7

MICHAEL E. PORTER, PHD

 

 

 

For

 

For

 

 

 

8

JAMES H. QUIGLEY

 

 

 

For

 

For

 

 

 

9

ANTHONY J. SINSKEY, SCD

 

 

 

For

 

For

 

2

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS MERRIMACK PHARMACEUTICALS, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

MYLAN INC.

 

Security

628530107

 

Meeting Type

Annual

Ticker Symbol

MYL

 

Meeting Date

24-May-2013

 


 

Record Date

22-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: HEATHER BRESCH

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: WENDY CAMERON

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ROBERT J. CINDRICH

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ROBERT J. COURY

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: NEIL DIMICK, C.P.A.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MELINA HIGGINS

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: DOUGLAS J. LEECH, C.P.A.

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: RAJIV MALIK

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: JOSEPH C. MAROON, M.D.

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: MARK W. PARRISH

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: RODNEY L. PIATT, C.P.A.

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: C.B. TODD

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR: RANDALL L. (PETE) VANDERVEEN, PH.D., R.PH., C.P.A.

 

Management

 

For

 

For

 

2.

 

RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF THE COMPANY.

 

Management

 

For

 

For

 

4.

 

CONSIDER A SHAREHOLDER PROPOSAL REQUESTING THE ADOPTION OF A MANDATORY POLICY REQUIRING THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR.

 

Shareholder

 

For

 

Against

 

 

NEKTAR THERAPEUTICS

 

Security

640268108

 

Meeting Type

Annual

Ticker Symbol

NKTR

 

Meeting Date

13-Jun-2013

 


 

Record Date

15-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: R. SCOTT GREER

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: CHRISTOPHER A. KUEBLER

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: LUTZ LINGNAU

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE A NON-BINDING ADVISORY RESOLUTION REGARDING OUR EXECUTIVE COMPENSATION (A “SAY-ON-PAY” VOTE).

 

Management

 

For

 

For

 

 

NEUROCRINE BIOSCIENCES, INC.

 

 

Security

64125C109

 

Meeting Type

Annual

Ticker Symbol

NBIX

 

Meeting Date

23-May-2013

Record Date

01-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CORINNE H. NEVINNY

 

 

 

For

 

For

 

 

 

2

RICHARD F. POPS

 

 

 

For

 

For

 

 

 

3

STEPHEN A. SHERWIN

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER FROM 5,500,000 TO 7,000,000.

 

Management

 

For

 

For

 

 


 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

09-Oct-2012

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

GENERAL MATTERS.

 

Management

 

For

 

For

 

2.

 

ADOPT AND APPROVE THE SECOND AMENDED AND RESTARTED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

3.

 

APPROVE THE AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE TO 12,036,986.

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

22-Apr-2013

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

GENERAL MATTERS.

 

Management

 

For

 

For

 

2.

 

DETERMINATION OF MILESTONE SATISFACTION.

 

Management

 

For

 

For

 

3.

 

APPROVE THE AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE TO 21,065,538.

 

Management

 

For

 

For

 

 

ONCOGENEX PHARMACEUTICALS, INC

 

Security

68230A106

 

Meeting Type

Annual

Ticker Symbol

OGXI

 

Meeting Date

24-May-2013

Record Date

28-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SCOTT CORMACK

 

 

 

For

 

For

 

 

 

2

NEIL CLENDENINN

 

 

 

For

 

For

 

 

 

3

JACK GOLDSTEIN

 

 

 

For

 

For

 

 

 

4

MARTIN MATTINGLY

 

 

 

For

 

For

 

 

 

5

STEWART PARKER

 

 

 

For

 

For

 

 

 

6

DAVID SMITH

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR 2010 PERFORMANCE INCENTIVE PLAN THAT WILL INCREASE THE TOTAL SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE 2010 PERFORMANCE INCENTIVE PLAN FROM 1,050,000 TO 2,050,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO ELIMINATE CUMULATIVE VOTING FOR THE ELECTION OF DIRECTORS.

 

Management

 

For

 

For

 

5.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED SHARES OF COMMON STOCK FROM 25,000,000 TO 50,000,000.

 

Management

 

For

 

For

 

 


 

ONYX PHARMACEUTICALS, INC.

 

Security

683399109

 

Meeting Type

Annual

Ticker Symbol

ONXX

 

Meeting Date

23-May-2013

Record Date

01-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CORINNE H. NEVINNY

 

 

 

For

 

For

 

 

 

2

THOMAS G. WIGGANS

 

 

 

For

 

For

 

2.

 

TO APPROVE THE COMPANY’S 2005 EQUITY INCENTIVE PLAN, AS AMENDED TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 3,800,000 SHARES.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE COMPANY’S 2013 CASH PERFORMANCE INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE COMPANY’S 1996 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 1,000,000 SHARES.

 

Management

 

For

 

For

 

5.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

6.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

PERRIGO COMPANY

 

Security

714290103

 

Meeting Type

Annual

Ticker Symbol

PRGO

 

Meeting Date

06-Nov-2012

Record Date

07-Sep-2012

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GARY M. COHEN

 

 

 

For

 

For

 

 

 

2

DAVID T. GIBBONS

 

 

 

For

 

For

 

 

 

3

RAN GOTTFRIED

 

 

 

For

 

For

 

 

 

4

ELLEN R. HOFFING

 

 

 

For

 

For

 

2.

 

AN ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2013.

 

Management

 

For

 

For

 

 

QUESTCOR PHARMACEUTICALS, INC.

 

Security

74835Y101

 

Meeting Type

Annual

Ticker Symbol

QCOR

 

Meeting Date

24-May-2013

Record Date

04-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DON M. BAILEY

 

 

 

For

 

For

 

 

 

2

NEAL C. BRADSHER

 

 

 

For

 

For

 

 

 

3

STEPHEN C. FARRELL

 

 

 

For

 

For

 

 

 

4

LOUIS SILVERMAN

 

 

 

For

 

For

 

 

 

5

VIRGIL D. THOMPSON

 

 

 

For

 

For

 

 

 

6

SCOTT M. WHITCUP

 

 

 

For

 

For

 

2.

 

PROPOSAL TO APPROVE AN ADVISORY (NON-BINDING) RESOLUTION REGARDING THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO RATIFY THE SELECTION OF BDO USA, LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 


 

REGENERON PHARMACEUTICALS, INC.

 

Security

75886F107

 

Meeting Type

Annual

Ticker Symbol

REGN

 

Meeting Date

14-Jun-2013

Record Date

17-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MICHAEL S. BROWN, M.D.

 

 

 

For

 

For

 

 

 

2

LEONARD S. SCHLEIFER

 

 

 

For

 

For

 

 

 

3

ERIC M. SHOOTER, PH.D.

 

 

 

For

 

For

 

 

 

4

GEORGE D. YANCOPOULOS

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

SAGENT PHARMACEUTICALS, INC

 

Security

786692103

 

Meeting Type

Annual

Ticker Symbol

SGNT

 

Meeting Date

13-Jun-2013

Record Date

16-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MARY TAYLOR BEHRENS

 

 

 

For

 

For

 

 

 

2

ANTHONY KRIZMAN

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE RETENTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ERNST & YOUNG LLP FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 


 

SHIRE PLC

 

Security

82481R106

 

Meeting Type

Annual

Ticker Symbol

SHPG

 

Meeting Date

30-Apr-2013

Record Date

21-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

O1

 

TO RECEIVE THE COMPANY’S ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND AUDITOR FOR THE YEAR ENDED DECEMBER 31, 2012.

 

Management

 

For

 

For

 

O2

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2012.

 

Management

 

For

 

For

 

O3

 

TO RE-ELECT WILLIAM BURNS AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O4

 

TO RE-ELECT MATTHEW EMMENS AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O5

 

TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O6

 

TO RE-ELECT GRAHAM HETHERINGTON AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O7

 

TO RE-ELECT DAVID KAPPLER AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O8

 

TO RE-ELECT SUSAN KILSBY AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O9

 

TO RE-ELECT ANNE MINTO AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O10

 

TO RE-ELECT DAVID STOUT AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O11

 

TO ELECT DR. STEVEN GILLIS AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O12

 

TO ELECT DR. FLEMMING ORNSKOV AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

O13

 

TO RE-APPOINT DELOITTE LLP AS THE COMPANY’S AUDITOR UNTIL THE CONCLUSION OF THE ANNUAL GENERAL MEETING OF THE COMPANY TO BE HELD IN 2014.

 

Management

 

For

 

For

 

 


 

O14

 

TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE OF THE BOARD TO DETERMINE THE REMUNERATION OF THE AUDITOR.

 

Management

 

For

 

For

 

O15

 

TO RESOLVE THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE COMPANY’S ARTICLES OF ASSOCIATION BE RENEWED, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

S16

 

TO RESOLVE THAT, SUBJECT TO THE PASSING OF RESOLUTION 15, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION) WHOLLY FOR CASH, CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE COMPANY’S ARTICLES OF ASSOCIATION, BE RENEWED, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

S17

 

TO RESOLVE THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED: (A) PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY; AND (B) PURSUANT TO ARTICLE 58A OF THE COMPANIES (JERSEY) LAW 1991, TO HOLD AS TREASURY SHARES ANY ORDINARY SHARES PURCHASED PURSUANT TO THE AUTHORITY CONFERRED BY PARAGRAPH (A) OF THIS RESOLUTION, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

S18

 

TO RESOLVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS’ NOTICE.

 

Management

 

For

 

For

 

 

SYNTA PHARMACEUTICALS CORPORATION

 

Security

87162T206

 

Meeting Type

Annual

Ticker Symbol

SNTA

 

Meeting Date

13-Jun-2013

Record Date

17-Apr-2013

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SAFI R. BAHCALL, PH.D.

 

 

 

For

 

For

 

 

 

2

BRUCE KOVNER

 

 

 

For

 

For

 

2.

 

PROPOSAL TO APPROVE AN AMENDMENT TO THE SYNTA PHARMACEUTICALS CORP. CHARTER TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK AVAILABLE FROM 100,000,000 TO 200,000,000.

 

Management

 

Against

 

Against

 

3.

 

PROPOSAL TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

4.

 

PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION.

 

Management

 

For

 

For

 

5.

 

PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF HOLDING A VOTE ON THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

1 Year

 

For

 

 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

881624209

 

Meeting Type

Annual

Ticker Symbol

TEVA

 

Meeting Date

12-Sep-2012

Record Date

13-Aug-2012

 

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE THE RESOLUTION OF THE BOARD OF DIRECTORS TO DECLARE AND DISTRIBUTE THE CASH DIVIDENDS FOR THE YEAR ENDED DECEMBER 31, 2011, PAID IN FOUR INSTALLMENTS IN AN AGGREGATE AMOUNT OF NIS 3.40 (APPROXIMATELY US$0.95, ACCORDING TO THE APPLICABLE EXCHANGE RATES PER ORDINARY SHARE (OR ADS).

 

Management

 

For

 

For

 

2A.

 

ELECTION OF DIRECTOR: DR. PHILLIP FROST

 

Management

 

For

 

For

 

2B.

 

ELECTION OF DIRECTOR: MR. ROGER ABRAVANEL

 

Management

 

For

 

For

 

2C.

 

ELECTION OF DIRECTOR: PROF. RICHARD A. LERNER

 

Management

 

For

 

For

 

2D.

 

ELECTION OF DIRECTOR: MS. GALIA MAOR

 

Management

 

For

 

For

 

2E.

 

ELECTION OF DIRECTOR: MR. EREZ VIGODMAN

 

Management

 

For

 

For

 

3A.

 

TO APPROVE THE PAYMENT TO EACH OF THE COMPANY’S DIRECTORS, OTHER THAN THE CHAIRMAN AND THE VICE CHAIRMAN OF THE BOARD OF DIRECTORS, OF AN ANNUAL FEE IN THE NIS EQUIVALENT OF US$190,000 (ACCORDING TO THE EXCHANGE RATE ON THE DATE OF APPROVAL BY SHAREHOLDERS) PLUS VAT (AS APPLICABLE) PLUS A PER MEETING FEE OF US$2,000 (ACCORDING TO THE EXCHANGE RATE ON THE DATE OF APPROVAL BY SHAREHOLDERS) PLUS VAT (AS APPLICABLE). SUCH PAYMENTS WILL BE ADJUSTED BASED ON THE ISRAELI CONSUMER PRICE INDEX SUBSEQUENT TO THE DATE OF APPROVAL BY SHAREHOLDERS.

 

Management

 

Against

 

Against

 

3B.

 

TO APPROVE THE REIMBURSEMENT AND REMUNERATION FOR DR. PHILLIP FROST, CHAIRMAN OF THE BOARD OF DIRECTORS, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

Against

 

Against

 

3C.

 

TO APPROVE PAYMENT TO PROF. MOSHE MANY, FOR HIS SERVICE AS VICE CHAIRMAN OF THE BOARD OF DIRECTORS, OF AN ANNUAL FEE IN THE NIS EQUIVALENT OF US$400,000 (ACCORDING TO THE EXCHANGE RATE ON THE DATE OF APPROVAL BY SHAREHOLDERS) PLUS VAT

 

Management

 

Against

 

Against

 

 


 

 

 

(AS APPLICABLE), FOR SUCH TIME AS PROF. MANY CONTINUES TO SERVE AS VICE CHAIRMAN OF THE BOARD OF DIRECTORS. SUCH PAYMENT WILL BE ADJUSTED BASED ON THE ISRAELI CONSUMER PRICE INDEX SUBSEQUENT TO THE DATE OF APPROVAL BY SHAREHOLDERS.

 

 

 

 

 

 

 

4.

 

TO APPROVE CERTAIN AMENDMENTS TO THE COMPANY’S ARTICLES OF ASSOCIATION IN THE MANNER DESCRIBED IN THE COMPANY’S PROXY STATEMENT AND AS REFLECTED IN THE AMENDED ARTICLES OF ASSOCIATION ATTACHED THERETO.

 

Management

 

For

 

For

 

5.

 

TO APPROVE INDEMNIFICATION AND RELEASE AGREEMENTS FOR THE DIRECTORS OF THE COMPANY.

 

Management

 

For

 

For

 

6.

 

TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL THE 2013 ANNUAL MEETING OF SHAREHOLDERS AND TO AUTHORIZE THE BOARD OF DIRECTORS TO DETERMINE ITS COMPENSATION, PROVIDED SUCH COMPENSATION IS ALSO APPROVED BY THE AUDIT COMMITTEE.

 

Management

 

For

 

For

 

 

TIBION CORPORATION

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

12-Apr-2013

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

SALE OF ASSETS AND RELATED TRANSACTIONS

 

Management

 

For

 

For

 

2.

 

APPROVAL OF MANAGEMENT INCENTIVE PLANS

 

Management

 

For

 

For

 

3.

 

APPROVAL OF EMPLOYEE RETENTION PAYMENTS

 

Management

 

For

 

For

 

4.

 

APPROVAL OF EMPLOYEE SEVERANCE PAYMENTS

 

Management

 

For

 

For

 

5.

 

CHANGE OF COMPANY NAME

 

Management

 

For

 

For

 

 

UNITED THERAPEUTICS CORPORATION

 

Security

91307C102

 

Meeting Type

Annual

Ticker Symbol

UTHR

 

Meeting Date

26-Jun-2013

Record Date

29-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CHRISTOPHER CAUSEY

 

 

 

For

 

For

 

 

 

2

RICHARD GILTNER

 

 

 

For

 

For

 

 

 

3

R. PAUL GRAY

 

 

 

For

 

For

 

2.

 

ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 


 

3.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS UNITED THERAPEUTICS CORPORATION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

 

VENITI, INC.

 

Security

N/A

 

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

 

Meeting Date

20-May-2013

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

APPROVAL OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2.

 

WAIVER OF PREEMPTIVE RIGHTS AND NOTICE

 

Management

 

For

 

For

 

3.

 

INCREASE IN SHARES RESERVED UNDER THE 2010 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

4.

 

OMNIBUS RESOLUTIONS

 

Management

 

For

 

For

 

 

VERASTEM, INC.

 

Security

92337C104

 

Meeting Type

Annual

Ticker Symbol

VSTM

 

Meeting Date

09-May-2013

Record Date

18-Apr-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RICHARD ALDRICH

 

 

 

For

 

For

 

 

 

2

MICHAEL KAUFFMAN, M.D.

 

 

 

For

 

For

 

 

 

3

S. LOUISE PHANSTIEL

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security

92532F100

Meeting Type

Annual

Ticker Symbol

VRTX

Meeting Date

08-May-2013

Record Date

11-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOSHUA BOGER

 

 

 

For

 

For

 

 

 

2

TERRENCE C. KEARNEY

 

 

 

For

 

For

 

 

 

3

YUCHUN LEE

 

 

 

For

 

For

 

 

 

4

ELAINE S. ULLIAN

 

 

 

For

 

For

 

2.

 

APPROVAL OF OUR 2013 STOCK AND OPTION PLAN.

 

Management

 

For

 

For

 

 


 

3.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

4.

 

ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

WARNER CHILCOTT PUBLIC LIMITED COMPANY

 

Security

G94368100

 

Meeting Type

Annual

Ticker Symbol

WCRX

 

Meeting Date

07-May-2013

Record Date

15-Mar-2013

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF CLASS I DIRECTOR: JOHN P. CONNAUGHTON

 

Management

 

For

 

For

 

1B.

 

ELECTION OF CLASS I DIRECTOR: TAMAR D. HOWSON

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, A REGISTERED PUBLIC ACCOUNTING FIRM, AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013, AND TO AUTHORIZE THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS’ REMUNERATION.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

 

 

 

 

/s/ Daniel R. Omstead

 

(Daniel R. Omstead, President)

 

Date

8/30/13

 

*Print the name and title of each signing officer under his or her signature.

 

2